Mohammed Qatanani
Hoofd Techniek/Wetenschap/O&O bij SCHOLAR ROCK HOLDING CORPORATION
Vermogen: 2 M $ op 30-04-2024
Actieve functies van Mohammed Qatanani
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-09-2022 | - |
Loopbaan van Mohammed Qatanani
Eerdere bekende functies van Mohammed Qatanani
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-02-2018 | 01-09-2021 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-07-2015 | 01-01-2018 |
Opleiding van Mohammed Qatanani
| American University of Beirut | Graduate Degree |
| Baylor College of Medicine | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Libanon | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Mohammed Qatanani
- Ervaring